63
Participants
Start Date
February 28, 2003
Primary Completion Date
January 31, 2004
Study Completion Date
March 31, 2014
OSI-774
150mg PO, days 1-28, cycle repeated every 28 days
Bevacizumab
10mg/kg, IV infusion, Days 1 and 15, 28 day cycles
Grand Rapids Oncology Program, Grand Rapids
Medical Oncology LLC, Baton Rouge
Collaborators (2)
AstraZeneca
INDUSTRY
Genentech, Inc.
INDUSTRY
SCRI Development Innovations, LLC
OTHER